Identification |
Name: | Calcium levomefolate |
Synonyms: | L-Glutamicacid, N-[4-[[(2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-,calcium salt (1:1), (S)-;L-Glutamic acid,N-[4-[[[(6S)-2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-,calcium salt (1:1) (9CI);Bodyfolin;Levomefolate calcium;L-Glutamic acid,N-[4-[[[(6S)-2-amino-3,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-,calcium salt (1:1);Metafolin;Nutrifolin; |
CAS: | 151533-22-1 |
Molecular Formula: | C20H23CaN7O6 |
Molecular Weight: | 497.52 |
InChI: | InChI=1/C20H25N7O6.Ca/c1-27-12(9-23-16-15(27)18(31)26-20(21)25-16)8-22-11-4-2-10(3-5-11)17(30)24-13(19(32)33)6-7-14(28)29;/h2-5,12-13,22H,6-9H2,1H3,(H,24,30)(H,28,29)(H,32,33)(H4,21,23,25,26,31);/q;+2/p-2/t12-,13-;/m0./s1 |
Molecular Structure: |
|
Properties |
Appearance: | Off-white to pale yellow solid |
Specification: |
Levomefolate calcium , its cas register number 151533-22-1. It also can be called L-glutamic acid, N-[4-[[[(6S)-2-amino-1,4,5,6,7,8-hexahydro-5-methyl-4-oxo-6-pteridinyl]methyl]amino]benzoyl]-, calcium salt (1:1) ; BAY 86-7660 ; BAY86-7660 ; Bodyfolin ; Calcium N-(4-((((6S)-2-amino-5-methyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl)methyl)amino)benzoyl)-L-glutamate ; LMCA ; Levomefolinate calcium ; Metafolin ; Nutrifolin ; and UNII-A9R10K3F2F . Its classification code are Prevention of folate deficiency and Treatment of folate deficiency.
|
Safety Data |
|
|